Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 02 09 2019
accepted: 05 05 2020
entrez: 30 5 2020
pubmed: 30 5 2020
medline: 12 8 2020
Statut: epublish

Résumé

Numerous studies have noted the presence of a dysexecutive component of the ALS-FTD. The most widely replicated result refers to the significantly reduced verbal fluency of ALS patients when compared to healthy people. As ALS patients have motor alterations that interfere with production, qualitative studies have the advantage of being independent of the degree of motor disability and revealing patients' cognitive state. This study examined the production differences between 42 ALS patients who presented with different degrees of dementia and motor impairment and 42 healthy people. Production processes were studied by extending the administration time of a letter fluency task to 2 minutes for the phonemic verbal fluency (PVF) and semantic verbal fluency (SVF) categories. This ensured that the qualitative aspects of verbal fluency were addressed, paying special attention to the new perseverations and intrusions, as well as any clinical correlates that may exist. The ALS patients produced a significantly lower number of responses in PVF (p = .017) and SVF (p = .008). The rest of the indicators for frontal lobe alteration also suggested the existence of a dysfunction. The most remarkable results were the number of intrusions on the PVF task, which was much higher in the ALS group (p = .002). However, the number of perseverations did not differ significantly. This study highlights the value of intrusions in addressing cognitive deterioration in ALS patients. This deterioration seems to be independent of the degree of motor impairment and of behavioural alterations. Therefore, the value of the intromissions on the verbal fluency task was highlighted as an indicator of a new cognitive alteration, which can be easily evaluated, even retrospectively.

Sections du résumé

BACKGROUND
Numerous studies have noted the presence of a dysexecutive component of the ALS-FTD. The most widely replicated result refers to the significantly reduced verbal fluency of ALS patients when compared to healthy people. As ALS patients have motor alterations that interfere with production, qualitative studies have the advantage of being independent of the degree of motor disability and revealing patients' cognitive state. This study examined the production differences between 42 ALS patients who presented with different degrees of dementia and motor impairment and 42 healthy people. Production processes were studied by extending the administration time of a letter fluency task to 2 minutes for the phonemic verbal fluency (PVF) and semantic verbal fluency (SVF) categories. This ensured that the qualitative aspects of verbal fluency were addressed, paying special attention to the new perseverations and intrusions, as well as any clinical correlates that may exist.
RESULTS
The ALS patients produced a significantly lower number of responses in PVF (p = .017) and SVF (p = .008). The rest of the indicators for frontal lobe alteration also suggested the existence of a dysfunction. The most remarkable results were the number of intrusions on the PVF task, which was much higher in the ALS group (p = .002). However, the number of perseverations did not differ significantly.
CONCLUSIONS
This study highlights the value of intrusions in addressing cognitive deterioration in ALS patients. This deterioration seems to be independent of the degree of motor impairment and of behavioural alterations. Therefore, the value of the intromissions on the verbal fluency task was highlighted as an indicator of a new cognitive alteration, which can be easily evaluated, even retrospectively.

Identifiants

pubmed: 32469951
doi: 10.1371/journal.pone.0233349
pii: PONE-D-19-20020
pmc: PMC7259757
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0233349

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Arch Neurol. 2006 Mar;63(3):345-52
pubmed: 16533961
Am J Med Sci. 2002 Aug;324(2):84-95
pubmed: 12186112
Acta Neuropsychiatr. 2006 Feb;18(1):38-41
pubmed: 26991981
Neuropsychologia. 1998 Jun;36(6):499-504
pubmed: 9705059
J Neurol Sci. 1993 Dec 1;120(1):22-8
pubmed: 8289076
J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):25-9
pubmed: 17519321
Brain Lang. 1984 Sep;23(1):148-58
pubmed: 6206914
Clin Neurol Neurosurg. 1997 May;99(2):79-86
pubmed: 9213049
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):711-712
pubmed: 28554960
Amyotroph Lateral Scler. 2010;11(1-2):27-37
pubmed: 19180349
Brain Imaging Behav. 2019 Jun;13(3):651-659
pubmed: 29748771
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):9-14
pubmed: 23781974
Amyotroph Lateral Scler. 2010 Oct;11(5):475-7
pubmed: 20509746
J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):416-8
pubmed: 8163988
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):102-6
pubmed: 10864613
J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):102-8
pubmed: 21836033
Neuropsychology. 2004 Jan;18(1):69-77
pubmed: 14744189
Semin Speech Lang. 2004 Nov;25(4):309-21
pubmed: 15599821
Nat Rev Neurol. 2013 Nov;9(11):617-28
pubmed: 24126629
Arch Neurol. 2007 Apr;64(4):530-4
pubmed: 17420314
Neurology. 2005 Aug 23;65(4):586-90
pubmed: 16116120
Neurology. 2005 Sep 13;65(5):719-25
pubmed: 16157905
J Clin Exp Neuropsychol. 2010 Mar;32(3):268-80
pubmed: 19657912
Can J Neurol Sci. 1997 Feb;24(1):29-36
pubmed: 9043744
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neurology. 2006 Jan 24;66(2):265-7
pubmed: 16434671
Lancet Neurol. 2013 Apr;12(4):368-80
pubmed: 23518330
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Clin Exp Neuropsychol. 2010 Nov;32(9):913-22
pubmed: 20390792
Alzheimer Dis Assoc Disord. 1998 Sep;12(3):152-62
pubmed: 9772017
Neuropsychologia. 2000;38(6):734-47
pubmed: 10689049
Cortex. 2012 Jul;48(7):936-44
pubmed: 21924711
J Neurol Neurosurg Psychiatry. 2013 May;84(5):494-8
pubmed: 23033353
Dement Geriatr Cogn Disord. 2008;25(2):109-14
pubmed: 18075249
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Neurol Neurosurg Psychiatry. 2002 May;72(5):602-7
pubmed: 11971046
J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):450-5
pubmed: 8937336
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):46-53
pubmed: 25544644
Amyotroph Lateral Scler. 2010;11(1-2):46-51
pubmed: 19722114
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):81-4
pubmed: 7823074
J Clin Exp Neuropsychol. 1998 Apr;20(2):137-43
pubmed: 9777467
Neuropsychologia. 1994 Dec;32(12):1487-94
pubmed: 7885578
Neurology. 2013 Apr 23;80(17):1590-7
pubmed: 23553481
Front Psychol. 2014 Jul 22;5:772
pubmed: 25101034
J Clin Exp Neuropsychol. 2010 Dec;32(10):1095-109
pubmed: 20582796
Amyotroph Lateral Scler. 2008 Dec;9(6):323-38
pubmed: 18752088
J Clin Exp Neuropsychol. 2000 Jun;22(3):370-8
pubmed: 10855044
Brain. 2004 Jul;127(Pt 7):1507-17
pubmed: 15163610
Neuropsychology. 2011 Mar;25(2):210-25
pubmed: 21381827
Ann Neurol. 2000 Apr;47(4):470-6
pubmed: 10762158
J Int Neuropsychol Soc. 2000 May;6(4):460-8
pubmed: 10902415
Brain. 2013 Nov;136(Pt 11):3290-304
pubmed: 24056536
BMJ Open. 2015 Sep 03;5(9):e007069
pubmed: 26338835
Amyotroph Lateral Scler. 2008 Feb;9(1):43-9
pubmed: 18270878
Lancet Neurol. 2008 May;7(5):409-16
pubmed: 18396105
J Clin Exp Neuropsychol. 2018 Oct;40(8):832-840
pubmed: 29502483
Brain. 1993 Dec;116 ( Pt 6):1399-423
pubmed: 8293278
Amyotroph Lateral Scler. 2012 Oct;13(6):493-501
pubmed: 22424127
J Int Neuropsychol Soc. 2012 Sep;18(5):809-18
pubmed: 22676844
J Exp Psychol Gen. 1997 Sep;126(3):211-27
pubmed: 9281831
Exp Aging Res. 2009 Jul-Sep;35(3):317-26
pubmed: 19449244
Dement Geriatr Cogn Disord. 1998 Mar-Apr;9(2):99-102
pubmed: 9524801
Neuropsychology. 2011 Jan;25(1):53-65
pubmed: 20919762
Neuropsychology. 2016 Oct;30(7):791-9
pubmed: 27054439
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):168-73
pubmed: 24769471

Auteurs

Manuel Perez (M)

University of Deusto, Vizcaya, Spain.

Imanol Amayra (I)

University of Deusto, Vizcaya, Spain.

Esther Lazaro (E)

University of Deusto, Vizcaya, Spain.

Maitane García (M)

University of Deusto, Vizcaya, Spain.

Oscar Martínez (O)

University of Deusto, Vizcaya, Spain.

Patricia Caballero (P)

University of Deusto, Vizcaya, Spain.
Clinical Psychology, Galdakao University Hospital, Vizcaya, Spain.

Sarah Berrocoso (S)

University of Deusto, Vizcaya, Spain.

Juan Francisco López-Paz (JF)

University of Deusto, Vizcaya, Spain.

Mohammad Al-Rashaida (M)

University of Deusto, Vizcaya, Spain.

Alicia Aurora Rodríguez (AA)

University of Deusto, Vizcaya, Spain.

Paula Luna (P)

University of Deusto, Vizcaya, Spain.

Luis Varona (L)

Department of Neurology, Basurto University Hospital, Vizcaya, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH